Inhibition of ULK1/2 and KRAS G12C controls tumor growth in preclinical models of lung cancer is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2024). On theSindex it has a DataRank of 0. It has been cited 3 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 3P30CA042014-30S2
Cancer Center Support Grant
National Institutes of Health
Grant: 5K08CA230151-03
Resistance Mechanisms to Combined Trametinib and 4-aminoquinolones in the Inhibition of Pancreatic Cancer
National Institutes of Health
Grant: 5R01CA176839-02
Targeting Oncogenic BRAF And PI3'-Kinase Signaling For Melanoma Therapy
National Institutes of Health
Grant: 5F31CA261116-02
Investigating KRAS Signaling and Autophagy Co-inhibition in KRAS-mutant Lung Cancer
National Institutes of Health
Grant: 3R01CA131261-11S1
Studying the initiation, progression and therapy of lung cancer in mouse models
National Institutes of Health
Grant: 5R01CA237404-04
Lineage specifiers governing pancreatic cancer growth and molecular subtype
National Institutes of Health
Grant: 5R01CA240317-04
Patho-Genetic Analysis of Invasive Mucinous Adenocarcinoma of the Lung
National Institutes of Health
Grant: 1R01CA082577-01
P53 MISSENSE MUTATIONS ON TUMORIGENESIS AND VIVO
National Institutes of Health
Grant: 5R01CA212415-04
Transcriptional Regulation of Lung Cancer Identity
Influential Citations
1
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals